Trial NCT01458548

View at ClinicalTrials.gov 
Org. Study IDs: PTLD-1

Last trial update was posted on 2011-10-25

MeSH Interventions

Rituximab

MeSH Conditions

Lymphoproliferative Disorders

Other Conditions

Post-transplantation Lymphoproliferative Disorder

Stopping Reasons

This study had an major amendment in 12/2006 introducing risk stratified sequential treatment (RSST). The modified protocol is registered with NCT00590447.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID